NCT02045849 - Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 28, 2014

Primary Completion Date

August 21, 2014

Study Completion Date

August 21, 2014

Conditions

Infections, Bacterial

Interventions

DRUG

GSK2140944 capsule

Immediate release capsule containing GSK2140944 and inactive formulation excipients with a unit dose strength of 500 mg

DRUG

GSK2140944 tablet

Immediate release tablet containing GSK2140944 and inactive formulation excipients with a unit dose strength of 750 mg

DRUG

Itraconazole capsule

Capsule containing Itraconazole with a unit dose strength of 100 mg

Trial Locations (1)

GSK Investigational Site, Overland Park